Broadfin Capital, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 46,049 shares at $9.71 ($444K) on 2017-11-28, disclosed to the SEC on 2017-11-30.
Open-market sale of $444k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.56 | 21,619 | $207K | 46.6% |
| 2 | $9.71 | 24,430 | $237K | 53.4% |
| Total | $9.64 avg | 46,049 | $444K | 100% |
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |